Hints and tips:
...V-over-a-tee look, à la Neil Barrett....
...“The real hurdle that’s going to have to be addressed is getting coverage by insurance companies for these medications,” said Patrick O’Neil, an expert on obesity at Medical University of South Carolina....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...s Sputnik V jab....
...Healthcare products Regulatory Agency approved the Pfizer/BioNTech vaccine on Wednesday....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...This article has been amended to clarify how the effectiveness of the vaccine was calculated Letter in response to this article: Job retention must be the aim in Brexit countdown / From Neil Carberry,...
...Neil Hume in London 43....
...(FT) News round-up Pfizer to boost cancer treatment portfolio with $11.4bn Array deal (FT) Nissan expands internal investigation into Carlos Ghosn (FT) Deutsche Bank to set up €50bn ‘bad bank’ as part...
...Star fund manager Neil Woodford campaigned for a new strategy before opting for “Glaxit” and dumping his shares last year. Other investors are now stepping up pressure for change....
...The 1984 case, formally known as “Chevron USA Inc v Natural Resources Defense Council Inc” formalised the legal doctrine that requires judges to defer to administrative agencies’ interpretation of federal...
...Letter in response to this report: Your quantum hype is out of this world / From Neil McNaughton...
...Collectively 30 companies, which include General Motors, Qualcomm and Pfizer, own nearly $900bn in US debt and equities. But the sheer scale is creating risk, say experts....
...To give you a sense of how desperate companies are to secure new assets you just need to remember how Sanofi started a bidding war for Medivation, only to lose out to Pfizer in August 2016, and how it later...
...“If they want to be serious in food they have to have volume,” says Neil Saunders, managing director at GlobalData Retail, a consultancy....
...Other signatories to the letter, organised by the National Association of Manufacturers, include the chief executives of Pfizer, Honeywell, Lockheed Martin, Eli Lilly and Cargill....
...Thanks for reading, –Neil Munshi Have any questions about the race, the candidates or the electoral process?...
...–Neil Munshi Follow us all on Twitter: @neiLmunshi, @barneyjopson, @Dimi and @Courtney_FT Click here for full FT coverage of the 2016 race....
...(WaPo) Clinton v Trump: clash of the operatives David Brock and Roger Stone are masters of the dark arts of politics – 2016 will be their greatest canvas....
...(CPI) Number of the day 73% v 28%The proportion of remaining delegates that Sanders would need to win in order to secure the nomination, compared to what Clinton needs....
...But prominent UK investor Neil Woodford appears to believe the Closed Triple has legs....
...Pfizer is planning to go further with the likely separation of its “established products” portfolio of older drugs by 2019....
...Neil Doshi, an analyst at Mizuho, says “it’s very hard to build a business around casual gamers....
International Edition